Genetic Variants of NRAMP1 and Hepcidin ( HAMP ) in Cancer Patients Infected with Human Herpesvirus-6
Viral Immunology · 01.12.2026 · 39 (9-10) · 325-333
DOI: 10.1177/08828245261487718 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viral Immunology, online erschienen am 17.09.2026. Verfasst von Nadia Habeeb Sarhan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Research Laboratory of Environmental Toxicology Microbiology and Health (LR17ES06), Faculty of Sciences, Sfax University, Sfax 3000, Tunisia. Hauptthemen laut MEDLINE: Hepcidins, Cation Transport Proteins, Neoplasms, Herpesvirus 6, Human. Die Arbeit nennt 35 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Human herpesvirus-6 (HHV-6) is involved in immune modulation and contributes to cancer development through interactions with host genetic factors. Hepcidin ( HAMP ) and NRAMP1 genes play essential roles in iron metabolism and innate immunity, yet their polymorphisms remain poorly investigated in HHV-6–associated cancers. This study investigated the association between HAMP and NRAMP1 gene polymorphisms and HHV-6 infection in 40 confirmed HHV-6–positive cancer patients compared with 40 non-cancer, HHV-6–negative controls. Genomic DNA was extracted and verified by agarose gel electrophoresis. Hepcidin polymorphisms were analyzed using Tetra-ARMS PCR, while NRAMP1 (3′UTR) polymorphism was detected by PCR-RFLP. Cancer patients exhibited wild-type, mutant, and heterozygous hepcidin genotypes, whereas controls predominantly showed the wild-type genotype. Although allele frequency analysis revealed no statistically significant difference for the G and TG + alleles between groups ( p = 0.23), the hepcidin A allele (521 bp) was more frequent among cancer patients, suggesting a possible association with increased cancer susceptibility (odds ratio = 2.111). For NRAMP1, three genotypic patterns were identified (TG−/TG−, TG+/TG+, and TG−/TG+), and while no significant between-group difference was detected ( p = 0.23), the TG+ allele demonstrated a potential two-fold increased cancer risk among carriers. These findings suggest that specific allelic variants—particularly the hepcidin A allele and NRAMP1 TG+ allele—may contribute to cancer susceptibility in HHV-6–infected individuals, highlighting a possible genetic–viral interaction that influences immune and iron-regulatory pathways in cancer development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Laboratory of Environmental Toxicology Microbiology and Health (LR17ES06), Faculty of Sciences, Sfax University, Sfax 3000, Tunisia.
- Department of Medical Microbiology, College of Medicine, University of Kufa, Najaf 54001, Iraq.
ORCID-Profile: Nadia Habeeb Sarhan
Zitieren
APA
Sarhan, N. H., Jabbar Yasir, S., & Gdoura, R. (2026). Genetic Variants of NRAMP1 and Hepcidin ( HAMP ) in Cancer Patients Infected with Human Herpesvirus-6. Viral Immunology, 39(9-10), 325-333. https://doi.org/10.1177/08828245261487718
Vancouver
Sarhan NH, Jabbar Yasir S, Gdoura R. Genetic Variants of NRAMP1 and Hepcidin ( HAMP ) in Cancer Patients Infected with Human Herpesvirus-6. Viral Immunology. 2026;39(9-10):325-333. doi:10.1177/08828245261487718
BibTeX
@article{Sarhan2026,
author = {Sarhan, Nadia Habeeb and Jabbar Yasir, Saif and Gdoura, Radhouane},
title = {Genetic Variants of NRAMP1 and Hepcidin ( HAMP ) in Cancer Patients Infected with Human Herpesvirus-6},
journal = {Viral Immunology},
year = {2026},
volume = {39},
number = {9-10},
pages = {325--333},
doi = {10.1177/08828245261487718}
}
EUVIMED